monoclonal antibodies

Disc Medicine nabs cash, big backers and biopharma drug deal
Fierce Biotech
Tue, 10/29/19 - 09:55 am
Disc Medicine
AbbVie
Novo Nodisk
monoclonal antibodies
Lilly's Taltz wins third approval, this time in patients with active ankylosing spondylitis
Endpoints
Mon, 08/26/19 - 09:33 am
Eli Lilly
monoclonal antibodies
Taltz
ankylosing spondylitis
FDA
GSK begins phase 3 trial for otilimab in patients with rheumatoid arthritis
Pharmaceutical Business Review
Sun, 07/7/19 - 11:15 am
GSK
clinical trials
rheumatoid arthritis
otilimab
monoclonal antibodies
Rivals’ disappointing results in asthma trial drag down shares of Anaptys Bio
Stat
Fri, 06/21/19 - 10:00 am
Sanofi
Regeneron
IL-33
asthma
monoclonal antibodies
REGN3500
AnaptysBio
Dupixent
Novartis plots to retain hives patients with monoclonal antibody that outshines Xolair
Endpoints
Tue, 12/4/18 - 09:43 am
Novartis
hives
monoclonal antibodies
ligelizumab
clinical trials
BeiGene Initiates Ph III Trial of PD-1 Inhibitor Tislelizumab + Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer in China
CP Wire
Wed, 07/25/18 - 03:11 pm
BeiGene
Celgene
tislelizumab
China
monoclonal antibodies
Boehringer Ingelheim Licenses Novel TCRm Antibody for Cancer Treatment
CP Wire
Tue, 07/17/18 - 09:56 am
Boehringer Ingelheim
Eureka Therapeutics
monoclonal antibodies
Boehringer Ingelheim Licenses Novel TCRm Antibody for Cancer Treatment
Tue, 07/17/18 - 09:52 am
Boehringer Ingelheim
Eureka Therapeutics
monoclonal antibodies
Arsanis Discontinues Ph II Trial of ASN100
CP Wire
Thu, 06/28/18 - 09:48 am
Arsanis
ASN100
pneumonia
monoclonal antibodies
Migraine Breakthrough: Not So Fast
Forbes
Wed, 06/6/18 - 09:49 pm
Amgen
Novartis
Aimovig
migraines
adults
monoclonal antibodies
Lilly's experimental colitis drug posts positive Phase 2 data
Biopharma Dive
Wed, 06/6/18 - 03:04 pm
Eli Lilly
mirikizumab
ulcerative colitis
monoclonal antibodies
CDI Labs' Monoclonal Antibody Development Pipeline Featured in Nature Methods
CP Wire
Thu, 03/29/18 - 10:06 am
CDI Labs
monoclonal antibodies
drug development
FDA delays decision on Merck's C. diff drug
BioPharma Dive
Tue, 07/26/16 - 11:03 am
FDA
Merck
Clostridium Difficile
bezlotoxumab
monoclonal antibodies
The Novartis-Xencor Collaboration Agreement: The Details
Market Realist
Fri, 07/1/16 - 09:37 am
Novartis
Xencor
monoclonal antibodies
Sanofi and Regeneron report positive skin disease trial
Yahoo/Reuters
Mon, 06/6/16 - 10:46 am
Sanofi
Regeneron
dupilumab
monoclonal antibodies
clinical trials
Teva Shareholders Shrug Off Latest Collaborative Research Agreement
Yahoo/Benzinga
Wed, 02/3/16 - 08:43 am
Teva Pharmaceutical
shareholders
R&D
AbCellera
monoclonal antibodies
Teva and AbCellera Enter Into Agreement to Discover Rare Monoclonal Antibodies
Yahoo
Tue, 02/2/16 - 01:27 pm
Teva Pharmaceutical
AbCellera
monoclonal antibodies
Regeneron Announces Agreement with BARDA for the Development of New Antibody Treatment for Ebola
Yahoo
Tue, 09/22/15 - 09:33 am
Regeneron
BARDA
ebola virus
monoclonal antibodies
Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement
Yahoo
Fri, 10/17/14 - 09:56 am
Amgen
Sanofi
Regeneron
patents
alirocumab
monoclonal antibodies
evolocumab
Asthma: It’s a mAb, mAb, mAb, mAb world says analyst
Bio-Pharma Reporter
Fri, 09/5/14 - 11:20 am
asthma
monoclonal antibodies
Sanofi
Regeneron
Roche
GSK
AstraZeneca

Pages